Chulmin Cho
Research Subjects
Chulmin Cho has a total of 126 co-authors. Here are the top co-authors by number of shared publications:
- Loren J. Martin
Department of Cell and Systems Biology, University of Toronto; Toronto, Ontario, M5S 3G5, Canada
7 shared publications - Jeffrey S. Mogil
Department of Psychology, McGill University, Montreal, QC, Canada.
4 shared publications - Chul Geun Kim
Department of Life Science and Research Institute for Natural Sciences, College of Natural Sciences, Hanyang University, Seoul 04763, Korea
3 shared publications - Hemant K. Paudel
Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, Quebec H4H 1R3, Canada; Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec H4H 1R3, Canada
3 shared publications Ryen MacDonald
Lady Davis Institute for Medical Research, Jewish General HospitalMontreal, QC, Canada
3 shared publicationsBang-Jin Kim
Department of Animal Science and Technology, Chung-Ang University, Ansung 456-756, Korea
2 shared publications
Latest Publications
- Open Access
Whole-brain analyses identify anterior cingulate μ-opioid signaling as a critical mediator of placebo analgesia in neuropathic pain
Placebo analgesia reflects the capacity of learning and expectation to engage endogenous pain-control systems, yet the neural circuits that support this phenomenon remain poorly understood. Here, we establish a conditioning-based placebo analgesia paradigm in mice following peripheral nerve injury and combine behavioral assessment with whole-brain activity mapping and targeted circuit manipulations to define its neural substrates. Conditioning with morphine produced robust placebo analgesia, expressed as reduced sensory sensitivity in the absence of drug. Brain-wide mapping of c-Fos expression revealed distributed changes across cortical and subcortical regions accompanied by a reorganization of functional connectivity, consistent with coordinated network-level engagement. Network analyses identified shifts in hub structure and selective strengthening and weakening of inter-regional interactions during placebo analgesia. Causal manipulations demonstrated a critical role for the anterior cingulate cortex, with excitatory activation of this region blocking placebo analgesia, whereas inhibitory manipulations had no effect. In contrast, perturbation of other candidate regions, including the basomedial amygdala and paraventricular thalamus, did not alter placebo responses. Finally, selective targeting of μ-opioid receptor–expressing neurons in the anterior cingulate cortex revealed that this cell population is necessary for the expression of placebo analgesia. Together, these findings reveal a brain-wide reorganization of network interactions underlying placebo analgesia and identify a specific cortical opioid circuit that gates its expression. One-Sentence Summary: Using a mouse model of nerve injury, this study shows that placebo analgesia arises from coordinated brain-wide network reorganization and is gated by μ-opioid receptor–expressing neurons in the anterior cingulate cortex.
Open AccessWhole-brain analyses identify anterior cingulate μ-opioid signaling as a critical mediator of placebo analgesia in neuropathic pain
Placebo analgesia reflects the capacity of learning and expectation to engage endogenous pain-control systems, yet the neural circuits that support this phenomenon remain poorly understood. Here, we establish a conditioning-based placebo analgesia paradigm in mice following peripheral nerve injury and combine behavioral assessment with whole-brain activity mapping and targeted circuit manipulations to define its neural substrates. Conditioning with morphine produced robust placebo analgesia, expressed as reduced sensory sensitivity in the absence of drug. Brain-wide mapping of c-Fos expression revealed distributed changes across cortical and subcortical regions accompanied by a reorganization of functional connectivity, consistent with coordinated network-level engagement. Network analyses identified shifts in hub structure and selective strengthening and weakening of inter-regional interactions during placebo analgesia. Causal manipulations demonstrated a critical role for the anterior cingulate cortex, with excitatory activation of this region blocking placebo analgesia, whereas inhibitory manipulations had no effect. In contrast, perturbation of other candidate regions, including the basomedial amygdala and paraventricular thalamus, did not alter placebo responses. Finally, selective targeting of μ-opioid receptor–expressing neurons in the anterior cingulate cortex revealed that this cell population is necessary for the expression of placebo analgesia. Together, these findings reveal a brain-wide reorganization of network interactions underlying placebo analgesia and identify a specific cortical opioid circuit that gates its expression. One-Sentence Summary: Using a mouse model of nerve injury, this study shows that placebo analgesia arises from coordinated brain-wide network reorganization and is gated by μ-opioid receptor–expressing neurons in the anterior cingulate cortex.
- Open Access
- 20 November 2020
- Published by Wolters Kluwer Health in Pain
- Vol. 162 (5) , 1416-1425
Cage-lid hanging behavior as a translationally relevant measure of pain in mice
The development of new analgesic drugs has been hampered by the inability to translate preclinical findings to humans. This failure is due in part to the weak connection between commonly used pain outcome measures in rodents and the clinical symptoms of chronic pain. Most rodent studies rely on the use of experimenter-evoked measures of pain and assess behavior under ethologically unnatural conditions, which limits the translational potential of preclinical research. Here, we addressed this problem by conducting an unbiased, prospective study of behavioral changes in mice within a natural homecage environment using conventional preclinical pain assays. Unexpectedly, we observed that cage-lid hanging, a species-specific elective behavior, was the only homecage behavior reliably impacted by pain assays. Noxious stimuli reduced hanging behavior in an intensity-dependent manner, and the reduction in hanging could be restored by analgesics. Finally, we developed an automated approach to assess hanging behavior. Collectively, our results indicate that the depression of hanging behavior is a novel, ethologically valid, and translationally relevant pain outcome measure in mice that could facilitate the study of pain and analgesic development.
- 20 November 2020
- Published by Wolters Kluwer Health in Pain
- Vol. 162 (5) , 1416-1425
Open AccessCage-lid hanging behavior as a translationally relevant measure of pain in mice
The development of new analgesic drugs has been hampered by the inability to translate preclinical findings to humans. This failure is due in part to the weak connection between commonly used pain outcome measures in rodents and the clinical symptoms of chronic pain. Most rodent studies rely on the use of experimenter-evoked measures of pain and assess behavior under ethologically unnatural conditions, which limits the translational potential of preclinical research. Here, we addressed this problem by conducting an unbiased, prospective study of behavioral changes in mice within a natural homecage environment using conventional preclinical pain assays. Unexpectedly, we observed that cage-lid hanging, a species-specific elective behavior, was the only homecage behavior reliably impacted by pain assays. Noxious stimuli reduced hanging behavior in an intensity-dependent manner, and the reduction in hanging could be restored by analgesics. Finally, we developed an automated approach to assess hanging behavior. Collectively, our results indicate that the depression of hanging behavior is a novel, ethologically valid, and translationally relevant pain outcome measure in mice that could facilitate the study of pain and analgesic development.
- 1 February 2020
- Published by Elsevier in Current Biology
- Vol. 30 (3) , 556-559
Male-Specific Conditioned Pain Hypersensitivity in Mice and Humans
- 1 February 2020
- Published by Elsevier in Current Biology
- Vol. 30 (3) , 556-559
Male-Specific Conditioned Pain Hypersensitivity in Mice and Humans
- Open Access
- 23 January 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-9
Evaluating analgesic efficacy and administration route following craniotomy in mice using the grimace scale
Most research laboratories abide by guidelines and mandates set by their research institution regarding the administration of analgesics to control pain during the postoperative period. Unfortunately, measuring pain originating from the head is difficult, making adequate decisions regarding pain control following stereotaxic surgery problematic. In addition, most postsurgical analgesia protocols require multiple injections over several days, which may cause stress and distress during a critical recovery period. Here we sought to (1) assess the degree of postoperative pain following craniotomy in mice, (2) compare the efficacy of three common rodent analgesics (carprofen, meloxicam and buprenorphine) for reducing this pain and (3) determine whether the route of administration (injected or self-administered through the drinking supply) influenced pain relief post-craniotomy. Using the mouse grimace scale (MGS), we found that injectable analgesics were significantly more effective at relieving post-craniotomy pain, however, both routes of administration decreased pain scores in the first 24 h postsurgery. Specifically, buprenorphine administered independently of administration route was the most effective at reducing MGS scores, however, female mice showed greater sensitivity to carprofen when administered through the water supply. Although it is necessary to provide laboratory animals with analgesics after an invasive procedure, there remains a gap in the literature regarding the degree of craniotomy-related pain in rodents and the efficacy of alternative routes of administration. Our study highlights the limitations of administering drugs through the drinking supply, even at doses that are considered to be higher than those currently recommended by most research institutions for treating pain of mild to moderate severity.
- 23 January 2019
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-9
Open AccessEvaluating analgesic efficacy and administration route following craniotomy in mice using the grimace scale
Most research laboratories abide by guidelines and mandates set by their research institution regarding the administration of analgesics to control pain during the postoperative period. Unfortunately, measuring pain originating from the head is difficult, making adequate decisions regarding pain control following stereotaxic surgery problematic. In addition, most postsurgical analgesia protocols require multiple injections over several days, which may cause stress and distress during a critical recovery period. Here we sought to (1) assess the degree of postoperative pain following craniotomy in mice, (2) compare the efficacy of three common rodent analgesics (carprofen, meloxicam and buprenorphine) for reducing this pain and (3) determine whether the route of administration (injected or self-administered through the drinking supply) influenced pain relief post-craniotomy. Using the mouse grimace scale (MGS), we found that injectable analgesics were significantly more effective at relieving post-craniotomy pain, however, both routes of administration decreased pain scores in the first 24 h postsurgery. Specifically, buprenorphine administered independently of administration route was the most effective at reducing MGS scores, however, female mice showed greater sensitivity to carprofen when administered through the water supply. Although it is necessary to provide laboratory animals with analgesics after an invasive procedure, there remains a gap in the literature regarding the degree of craniotomy-related pain in rodents and the efficacy of alternative routes of administration. Our study highlights the limitations of administering drugs through the drinking supply, even at doses that are considered to be higher than those currently recommended by most research institutions for treating pain of mild to moderate severity.
- 1 January 2019
- Published by Elsevier in Current Biology
- Vol. 29 (2) , 192-201.e4
Male-Specific Conditioned Pain Hypersensitivity in Mice and Humans
- 1 January 2019
- Published by Elsevier in Current Biology
- Vol. 29 (2) , 192-201.e4
Male-Specific Conditioned Pain Hypersensitivity in Mice and Humans
- Open Access
- 1 August 2018
- Published by Elsevier in Neurobiology of Pain
- Vol. 4, 27-34
Revealing brain mechanisms of mTOR-mediated translational regulation: Implications for chronic pain
- 1 August 2018
- Published by Elsevier in Neurobiology of Pain
- Vol. 4, 27-34
Open AccessRevealing brain mechanisms of mTOR-mediated translational regulation: Implications for chronic pain
- Open Access
- 7 August 2017
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 127 (9) , 3353-3366
Epiregulin and EGFR interactions are involved in pain processing
The EGFR belongs to the well-studied ErbB family of receptor tyrosine kinases. EGFR is activated by numerous endogenous ligands that promote cellular growth, proliferation, and tissue regeneration. In the present study, we have demonstrated a role for EGFR and its natural ligand, epiregulin (EREG), in pain processing. We show that inhibition of EGFR with clinically available compounds strongly reduced nocifensive behavior in mouse models of inflammatory and chronic pain. EREG-mediated activation of EGFR enhanced nociception through a mechanism involving the PI3K/AKT/mTOR pathway and matrix metalloproteinase-9. Moreover, EREG application potentiated capsaicin-induced calcium influx in a subset of sensory neurons. Both the EGFR and EREG genes displayed a genetic association with the development of chronic pain in several clinical cohorts of temporomandibular disorder. Thus, EGFR and EREG may be suitable therapeutic targets for persistent pain conditions.
- 7 August 2017
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 127 (9) , 3353-3366
Open AccessEpiregulin and EGFR interactions are involved in pain processing
The EGFR belongs to the well-studied ErbB family of receptor tyrosine kinases. EGFR is activated by numerous endogenous ligands that promote cellular growth, proliferation, and tissue regeneration. In the present study, we have demonstrated a role for EGFR and its natural ligand, epiregulin (EREG), in pain processing. We show that inhibition of EGFR with clinically available compounds strongly reduced nocifensive behavior in mouse models of inflammatory and chronic pain. EREG-mediated activation of EGFR enhanced nociception through a mechanism involving the PI3K/AKT/mTOR pathway and matrix metalloproteinase-9. Moreover, EREG application potentiated capsaicin-induced calcium influx in a subset of sensory neurons. Both the EGFR and EREG genes displayed a genetic association with the development of chronic pain in several clinical cohorts of temporomandibular disorder. Thus, EGFR and EREG may be suitable therapeutic targets for persistent pain conditions.
- Open Access
- 3 August 2017
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 9, 258
A Novel Egr-1-Agrin Pathway and Potential Implications for Regulation of Synaptic Physiology and Homeostasis at the Neuromuscular Junction
Synaptic transmission requires intricate coordination of the components involved in processing of incoming signals, formation and stabilization of synaptic machinery, neurotransmission, and in all related signaling pathways. Changes to any of these components cause synaptic imbalance and disruption of neuronal circuitry. Extensive studies at the neuromuscular junction (NMJ) have greatly aided in the current understanding of synapses and served to elucidate the underlying physiology as well as associated adaptive and homeostatic processes. The heparansulfate proteoglycan agrin is a vital component of the NMJ, mediating synaptic formation and maintenance in both brain and muscle, but very little is known about direct control of its expression. Here, we investigated the relationship between agrin and transcription factor early growth response-1 (Egr-1), as Egr-1 regulates the expression of many genes involved in synaptic homeostasis and plasticity. Using chromatin immunoprecipitation, cell culture with cell lines derived from brain and muscle, and animal models, we show that Egr-1 binds to the AGRN gene locus and suppresses its expression. When compared with wild type (WT), mice deficient in Egr-1 (Egr-1-/-) display a marked increase in AGRN mRNA and agrin full-length and cleavage fragment protein levels, including the 22 kDa, C-terminal fragment in brain and muscle tissue homogenate. Because agrin is a crucial component of the NMJ, we explored possible physiological implications of the Egr-1-agrin relationship. In the diaphragm, Egr-1-/- mice display increased NMJ motor endplate density, individual area, and area of innervation. In addition to increased density, soleus NMJs also display an increase in fragmented and faint endplates in Egr-1-/- versus WT mice. Moreover, the soleus NMJ electrophysiology of Egr-1-/- mice revealed increased quantal content and motor testing showed decreased movement and limb muscle strength compared with WT. This study provides evidence for the potential involvement of a novel Egr-1-agrin pathway in synaptic homeostatic and compensatory mechanisms at the NMJ. Synaptic homeostasis is greatly affected by the process of aging. These and other data suggest that changes in Egr-1 expression may directly or indirectly promote age-related pathologies.
- 3 August 2017
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 9, 258
Open AccessA Novel Egr-1-Agrin Pathway and Potential Implications for Regulation of Synaptic Physiology and Homeostasis at the Neuromuscular Junction
Synaptic transmission requires intricate coordination of the components involved in processing of incoming signals, formation and stabilization of synaptic machinery, neurotransmission, and in all related signaling pathways. Changes to any of these components cause synaptic imbalance and disruption of neuronal circuitry. Extensive studies at the neuromuscular junction (NMJ) have greatly aided in the current understanding of synapses and served to elucidate the underlying physiology as well as associated adaptive and homeostatic processes. The heparansulfate proteoglycan agrin is a vital component of the NMJ, mediating synaptic formation and maintenance in both brain and muscle, but very little is known about direct control of its expression. Here, we investigated the relationship between agrin and transcription factor early growth response-1 (Egr-1), as Egr-1 regulates the expression of many genes involved in synaptic homeostasis and plasticity. Using chromatin immunoprecipitation, cell culture with cell lines derived from brain and muscle, and animal models, we show that Egr-1 binds to the AGRN gene locus and suppresses its expression. When compared with wild type (WT), mice deficient in Egr-1 (Egr-1-/-) display a marked increase in AGRN mRNA and agrin full-length and cleavage fragment protein levels, including the 22 kDa, C-terminal fragment in brain and muscle tissue homogenate. Because agrin is a crucial component of the NMJ, we explored possible physiological implications of the Egr-1-agrin relationship. In the diaphragm, Egr-1-/- mice display increased NMJ motor endplate density, individual area, and area of innervation. In addition to increased density, soleus NMJs also display an increase in fragmented and faint endplates in Egr-1-/- versus WT mice. Moreover, the soleus NMJ electrophysiology of Egr-1-/- mice revealed increased quantal content and motor testing showed decreased movement and limb muscle strength compared with WT. This study provides evidence for the potential involvement of a novel Egr-1-agrin pathway in synaptic homeostatic and compensatory mechanisms at the NMJ. Synaptic homeostasis is greatly affected by the process of aging. These and other data suggest that changes in Egr-1 expression may directly or indirectly promote age-related pathologies.
- 26 April 2017
- Published by Wiley in Journal of Neurochemistry
- Vol. 142 (1) , 56-73
Early growth response‐1‐mediated down‐regulation of drebrin correlates with loss of dendritic spines
Post‐synaptic dendritic spines are structurally composed of actin cytoskeleton, which undergoes dynamic morphological changes to accommodate incoming synaptic activity. Drebrin is an actin‐binding protein highly expressed in dendritic spines that serves an important role in regulating spine morphology. Functionally, loss of drebrin directly correlates with deficits in learning and memory, as is the case observed in Alzheimer's disease. Despite these findings, the regulatory factor responsible for drebrin loss remains unclear. Here, we show that early growth response‐1 (Egr‐1), an inducible zinc finger transcription factor, down‐regulates drebrin expression. Chromatin immunoprecipitation analyses identified Egr‐1 binding sites upstream of the drebrin start site in neuronal cells. Over‐expression of Egr‐1 in vitro in primary hippocampal neurons or in vivo in homogenates prepared from the hippocampi of an inducible mouse model of Egr‐1 show reduced drebrin mRNA and protein levels. Conversely, increased drebrin was detected in hippocampal samples isolated from Egr‐1‐deficient brain. These data demonstrate that Egr‐1 interacts with the drebrin promoter and negatively regulates drebrin expression. Furthermore, immunocytochemical and Golgi staining analyses revealed reduced drebrin protein and dendritic spine density as well as reduced expression of synaptic markers in in vitro hippocampal neurons over‐expressing Egr‐1 and in vivo inducible mouse model of Egr‐1. In contrast, increased drebrin expression correlated with increased dendritic spine density was detected in samples from Egr‐1‐deficient mice. These data provide evidence that Egr‐1 is a novel regulator of drebrin expression, which is linked to changes in dendritic spine density. image
- 26 April 2017
- Published by Wiley in Journal of Neurochemistry
- Vol. 142 (1) , 56-73
Early growth response‐1‐mediated down‐regulation of drebrin correlates with loss of dendritic spines
Post‐synaptic dendritic spines are structurally composed of actin cytoskeleton, which undergoes dynamic morphological changes to accommodate incoming synaptic activity. Drebrin is an actin‐binding protein highly expressed in dendritic spines that serves an important role in regulating spine morphology. Functionally, loss of drebrin directly correlates with deficits in learning and memory, as is the case observed in Alzheimer's disease. Despite these findings, the regulatory factor responsible for drebrin loss remains unclear. Here, we show that early growth response‐1 (Egr‐1), an inducible zinc finger transcription factor, down‐regulates drebrin expression. Chromatin immunoprecipitation analyses identified Egr‐1 binding sites upstream of the drebrin start site in neuronal cells. Over‐expression of Egr‐1 in vitro in primary hippocampal neurons or in vivo in homogenates prepared from the hippocampi of an inducible mouse model of Egr‐1 show reduced drebrin mRNA and protein levels. Conversely, increased drebrin was detected in hippocampal samples isolated from Egr‐1‐deficient brain. These data demonstrate that Egr‐1 interacts with the drebrin promoter and negatively regulates drebrin expression. Furthermore, immunocytochemical and Golgi staining analyses revealed reduced drebrin protein and dendritic spine density as well as reduced expression of synaptic markers in in vitro hippocampal neurons over‐expressing Egr‐1 and in vivo inducible mouse model of Egr‐1. In contrast, increased drebrin expression correlated with increased dendritic spine density was detected in samples from Egr‐1‐deficient mice. These data provide evidence that Egr‐1 is a novel regulator of drebrin expression, which is linked to changes in dendritic spine density. image
- 1 January 2014
- Published by Oxford University Press (OUP) in Journal of Animal Science
- Vol. 92 (1) , 106-118
Lentiviral modification of enriched populations of bovine male gonocytes1
Undifferentiated germ cells have the capacity to develop into sperm capable of fertilizing oocytes and contributing genetic material to subsequent generations. The most primitive prepubertal undifferentiated germ cells include gonocytes and undifferentiated spermatogonia, including spermatogonial stem cells (SSC). Gonocytes, present in the testis at birth, differentiate into SSC, which maintain spermatogenesis for the remainder of the male’s life. Because of their capacity to contribute to lifelong spermatogenesis, undifferentiated germ cells are attractive targets for genetic modification to produce transgenic animals, including cattle. To maximize the efficiency of genetic modification of bovine gonocytes and SSC, effective enrichment techniques need to be developed. Selection of bovine gonocytes using differential plating was improved 8-fold (P < 0.001) when using a combination of extracellular matrix proteins, including laminin, fibronectin, collagen type IV, and gelatin, compared to using laminin and gelatin alone. Selected cells labeled with PKH26 formed colonies of donor-derived germ cells after transplantation into recipient mouse testes, indicating putative stem cell function. Significantly more colonies (P < 0.001) per 1 × 105 viable transplanted cells were formed from isolated nonadherent cells (203 ± 23.2) compared to adherent (20 ± 2.7) or Percoll (45.5 ± 4.5) selected cells. After selection, some gonocytes were transduced using a lentiviral vector containing the transgene for the enhanced green fluorescent protein. Transduction efficiency was 17%. Collectively, these data demonstrate effective methods for the selection and genetic modification of bovine undifferentiated germ cells. Copyright © 2014. American Society of Animal Science .
- 1 January 2014
- Published by Oxford University Press (OUP) in Journal of Animal Science
- Vol. 92 (1) , 106-118
Lentiviral modification of enriched populations of bovine male gonocytes1
Undifferentiated germ cells have the capacity to develop into sperm capable of fertilizing oocytes and contributing genetic material to subsequent generations. The most primitive prepubertal undifferentiated germ cells include gonocytes and undifferentiated spermatogonia, including spermatogonial stem cells (SSC). Gonocytes, present in the testis at birth, differentiate into SSC, which maintain spermatogenesis for the remainder of the male’s life. Because of their capacity to contribute to lifelong spermatogenesis, undifferentiated germ cells are attractive targets for genetic modification to produce transgenic animals, including cattle. To maximize the efficiency of genetic modification of bovine gonocytes and SSC, effective enrichment techniques need to be developed. Selection of bovine gonocytes using differential plating was improved 8-fold (P < 0.001) when using a combination of extracellular matrix proteins, including laminin, fibronectin, collagen type IV, and gelatin, compared to using laminin and gelatin alone. Selected cells labeled with PKH26 formed colonies of donor-derived germ cells after transplantation into recipient mouse testes, indicating putative stem cell function. Significantly more colonies (P < 0.001) per 1 × 105 viable transplanted cells were formed from isolated nonadherent cells (203 ± 23.2) compared to adherent (20 ± 2.7) or Percoll (45.5 ± 4.5) selected cells. After selection, some gonocytes were transduced using a lentiviral vector containing the transgene for the enhanced green fluorescent protein. Transduction efficiency was 17%. Collectively, these data demonstrate effective methods for the selection and genetic modification of bovine undifferentiated germ cells. Copyright © 2014. American Society of Animal Science .